JP2025502191A5 - - Google Patents
Info
- Publication number
- JP2025502191A5 JP2025502191A5 JP2024541745A JP2024541745A JP2025502191A5 JP 2025502191 A5 JP2025502191 A5 JP 2025502191A5 JP 2024541745 A JP2024541745 A JP 2024541745A JP 2024541745 A JP2024541745 A JP 2024541745A JP 2025502191 A5 JP2025502191 A5 JP 2025502191A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- compound according
- independently
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298793P | 2022-01-12 | 2022-01-12 | |
| US63/298,793 | 2022-01-12 | ||
| US202263299261P | 2022-01-13 | 2022-01-13 | |
| US63/299,261 | 2022-01-13 | ||
| PCT/US2023/060594 WO2023137403A2 (en) | 2022-01-12 | 2023-01-12 | Compound comprising raltitrexed or 5-mthf linked to a therapeutic agent, composition, and method of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502191A JP2025502191A (ja) | 2025-01-24 |
| JP2025502191A5 true JP2025502191A5 (https=) | 2026-01-27 |
Family
ID=87279733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541745A Pending JP2025502191A (ja) | 2022-01-12 | 2023-01-12 | 治療剤に結合したラルチトレキセドまたは５－ｍｔｈｆを含む化合物、組成物、および使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250222117A1 (https=) |
| EP (1) | EP4463149A2 (https=) |
| JP (1) | JP2025502191A (https=) |
| KR (1) | KR20240150763A (https=) |
| CA (2) | CA3248149A1 (https=) |
| WO (1) | WO2023137403A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250036739A (ko) * | 2022-05-26 | 2025-03-14 | 퍼듀 리서치 파운데이션 | 소분자 약물 접합체와 car-발현 세포독성 림프구의 조합물 및 사용 방법 |
| WO2024186626A1 (en) * | 2023-03-03 | 2024-09-12 | Bolt Biotherapeutics, Inc. | Aza-bicyclic sting agonist immunoconjugates, and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111886000A (zh) * | 2018-03-20 | 2020-11-03 | 达纳-法伯癌症研究所股份有限公司 | 用于癌症治疗的组合物和方法 |
-
2023
- 2023-01-12 US US18/728,431 patent/US20250222117A1/en active Pending
- 2023-01-12 KR KR1020247027092A patent/KR20240150763A/ko active Pending
- 2023-01-12 EP EP23740851.3A patent/EP4463149A2/en active Pending
- 2023-01-12 WO PCT/US2023/060594 patent/WO2023137403A2/en not_active Ceased
- 2023-01-12 CA CA3248149A patent/CA3248149A1/en active Pending
- 2023-01-12 JP JP2024541745A patent/JP2025502191A/ja active Pending
- 2023-01-12 CA CA3248078A patent/CA3248078A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025502191A5 (https=) | ||
| ES2657907T3 (es) | Aplicaciones terapéuticas de ectoína | |
| EP3374369B1 (en) | Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof | |
| CA2725535C (en) | Modified drugs for use in liposomal nanoparticles | |
| CA3238758A1 (en) | Novel ionizable lipids and lipid nanoparticles and methods of using the same | |
| CA3143865A1 (en) | Lipid composition | |
| KR100687821B1 (ko) | 산화적 손상 및 내피세포 기능부전의 치료를 위한 스테로이드 질산염 | |
| WO2014138425A1 (en) | Cyclosporine a-steroid conjugates | |
| AU2015252859A1 (en) | Bone-selective osteogenic oxysterol bisphosphonate analogs | |
| RU2008100237A (ru) | ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ | |
| US20180021403A1 (en) | Combination Therapy | |
| HRP20160624T1 (hr) | Derivati sterola, postupci njihove pripreme, farmaceutski pripravci koji ih sadrže i njihova uporaba za liječenje multiplih glioblastoma | |
| KR20080039442A (ko) | 스테로이드 니트록시 유도체들 | |
| CA3248149A1 (en) | COMPOUND CONTAINING RALTITREXED OR 5-MTHF LINKED TO A THERAPEUTIC AGENT, COMPOSITION AND METHOD OF USE | |
| ES2368199T3 (es) | Derivados covalentes de alcanolamidas de ácidos monocarboxílicos y dicarboxílicos funcionalmente activos en el receptor cannabinoide cb2. | |
| EP3243841B1 (en) | Chondroitin sulfuric acid derivative and drug for treating bladder diseases | |
| JP2023510741A5 (https=) | ||
| JP2003530329A (ja) | 増大したバイオアベイラビリティを有する胆汁酸含有プロドラッグ | |
| EA027831B1 (ru) | СПОСОБ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ СОСТОЯНИЙ С ПРИМЕНЕНИЕМ S-[4-(3-ФТОР-3-МЕТИЛБУТИРИЛОКСИ)БУТ-2-ИНИЛ]6α,9α-ДИФТОР-17α-(ФУРАН-2-ИЛ)КАРБОНИЛОКСИ-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОАТА | |
| EP0470995A1 (en) | USE OF STEROIDS AS AN ANTI-FUNGI AGENT. | |
| CN118871104A (zh) | 包含连接至治疗剂的雷替曲塞或5-mthf的化合物、组合物及使用方法 | |
| JP2025542006A (ja) | ペプチド薬物コンジュゲート |